Jaundice Clinical Trial
Official title:
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
The purpose of this study is to compare the demographic, metabolic, and genomic
characteristics of patients who develop severe hyperbilirubinemia (serum bilirubin level in
the "high risk zone of greater than the 95th percentile based on the Bhutani nomogram) to
patients who never developed significant hyperbilirubinemia (bilirubin level in "low risk
zone of less than the 40th percentile" on Bhutani nomogram and who did not require any
treatment for hyperbilirubinemia). Our primary goal is to determine if common gene mutations
occur at a greater frequency in patients with severe hyperbilirubinemia than in neonates
without significant hyperbilirubinemia.
The gene mutations we will test for are:
- Glucose-6-phosphate Dehydrogenase Deficiency [G6PD] gene mutations
- African A- mutation (G202A;A376G)
- The common Mediterranean mutation (C563T)
- Two common Chinese mutations (G1376T and G1388A)
- UGT1A1 polymorphism. The UGT1A1 gene polymorphisms refer to those genetic defects found
to be associated with Gilbert's Syndrome, including a promoter defect (T-3263G) that
disrupts a transcription regulatory site, the TA repeats promoter polymorphism, and
four mutations within the coding region (G211A, C686A, C1091T, and T1456G).
- Gene polymorphism for the organic anion transporting protein (OATP-2)
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00360204 -
Improving Health Outcomes for New Mothers and Babies
|
Phase 3 | |
| Withdrawn |
NCT04021927 -
Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy
|
N/A | |
| Completed |
NCT00966719 -
Breastfeeding Support Intervention in Jaundiced Infants
|
N/A | |
| Completed |
NCT02033096 -
Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
|
||
| Terminated |
NCT01514058 -
A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction
|
N/A | |
| Active, not recruiting |
NCT01683708 -
Effectiveness Of Symbiotic Therapy In Jaundiced Patients
|
N/A | |
| Completed |
NCT01203410 -
Prediction of Jaundice in Term Infants
|
||
| Completed |
NCT01356030 -
Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer
|
N/A | |
| Not yet recruiting |
NCT06276738 -
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
|
||
| Completed |
NCT02787512 -
Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer
|
N/A | |
| Completed |
NCT02991339 -
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT00240123 -
Effect of Benadryl Sedation During ERCP or EUS
|
Phase 1 | |
| Completed |
NCT02926131 -
A Study to Evaluate a New Jaundice Stick Test
|
||
| Completed |
NCT01499537 -
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
|
N/A | |
| Active, not recruiting |
NCT02376907 -
Biliary Drainage in Patients With Duodenal Metal Stent
|
N/A | |
| Terminated |
NCT01887041 -
Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer
|
Phase 4 | |
| Recruiting |
NCT06173947 -
SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
|
||
| Active, not recruiting |
NCT04271176 -
Jaundice as Initial Presentation of Liver Hydatidosis (ICTEHIDA)
|
||
| Not yet recruiting |
NCT06232174 -
Value of Transcutaneous Bilirubin Devices
|
||
| Completed |
NCT01976936 -
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
|
Phase 2 |